GL Pharm Tech Corp. (KOSDAQ: 204840)

GL Pharm Tech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	86,858	70,834	46,578	76,699	68,455	39,363
Market Cap Growth	66.98%	52.08%	-39.27%	12.04%	73.91%	-69.66%
Enterprise Value	93,231	82,845	55,794	82,225	76,787	52,935
Last Close Price	1130.00	1136.00	750.00	1240.00	1450.00	1100.00
PE Ratio	-	-18.86	-57.69	-16.92	-19.33	-7.14
PS Ratio	2.71	2.72	2.78	6.17	5.71	3.71
PB Ratio	4.41	5.77	2.89	4.39	4.78	16.67
P/FCF Ratio	-16.94	-16.33	-6.04	-21.31	-18.18	-19.10
P/OCF Ratio	-18.59	-18.84	-36.71	-33.77	-25.68	-36.72
EV/Sales Ratio	3.34	3.18	3.34	6.62	6.41	4.99
EV/EBITDA Ratio	-52.94	-76.01	-50.26	-123.29	-110.26	-41.41
EV/EBIT Ratio	-24.69	-25.66	-17.14	-30.38	-29.03	-16.93
EV/FCF Ratio	-19.42	-19.09	-7.24	-22.84	-20.40	-25.69
Debt / Equity Ratio	0.81	1.45	0.86	0.45	0.91	6.65
Debt / FCF Ratio	-3.30	-4.10	-1.80	-2.19	-3.46	-7.62
Asset Turnover	0.65	0.64	0.46	0.37	0.39	0.37
Inventory Turnover	2.61	2.86	2.67	2.83	3.59	4.66
Quick Ratio	0.98	0.81	0.79	2.02	1.71	0.26
Current Ratio	1.48	1.35	1.24	2.73	2.08	0.39
Return on Equity (ROE)	-25.07%	-26.42%	-4.71%	-23.49%	-40.25%	-108.38%
Return on Assets (ROA)	-5.03%	-5.00%	-5.59%	-5.06%	-5.38%	-6.73%
Return on Capital (ROIC)	-6.51%	-6.72%	-7.35%	-6.42%	-7.28%	-9.50%
Earnings Yield	-5.63%	-5.29%	-1.70%	-4.86%	-4.90%	-14.01%
FCF Yield	-5.53%	-6.13%	-16.55%	-4.69%	-5.50%	-5.24%
Buyback Yield / Dilution	-7.73%	-0.34%	-21.96%	-13.03%	-25.74%	-8.23%
Total Shareholder Return	-7.73%	-0.34%	-21.96%	-13.03%	-25.74%	-8.23%

Source: S&P Capital IQ. Standard template. Financial Sources.